HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.

AbstractOBJECTIVE:
To verify whether a synthetic therapeutic killer decapeptide (KP), a functional mimotope of a yeast killer toxin with wide-spectrum microbicidal activity, inclusive of AIDS-related opportunistic micro-organisms, through interaction with beta-glucan receptors, which has been found to possess sequence homology with critical segments in gp160 V1/V2 and V3 loops, may also be inhibiting HIV-1 replication.
METHODS:
Primary peripheral blood mononuclear cells (PBMCs) cultures established from HIV-1-infected patients were treated with KP in comparison with zidovudine and supernatants and cells were harvested for analysis of HIV RNA and proviral contents, respectively. Virus production in exogenous in-vitro PBMCs infection with lymphocytotropic and monocytotropic HIV-1 strains was also assessed in presence of KP by enzyme-linked immunosorbent assay HIV p24 gag antigen detection. The binding affinity of KP to CD4, CCR5 and CXCR4 was evaluated on CD4-CCR5 or CD4-CXCR4 transfected astroglioma cell lines.
RESULTS:
KP was shown to be devoid of cytotoxicity on PBMCs and to inhibit HIV-1 replication in PBMCs of a patient in the acute phase of infection. The antiretroviral activity of KP, which proved to be more potent than zidovudine at micromolar concentrations, is abolished by beta 1,3-glucan but not by beta 1,6-glucan. Down-regulation of CCR5 co-receptor, and/or physical block of the gp120-receptor interaction are possible mechanisms of KP activity.
CONCLUSION:
KP appears to be the first antibody-derived short peptide displaying an inhibitory activity against HIV-1 and related opportunistic micro-organisms by different mechanisms of action.
AuthorsClaudio Casoli, Elisabetta Pilotti, Carlo Federico Perno, Emanuela Balestra, Eugenia Polverini, Antonio Cassone, Stefania Conti, Walter Magliani, Luciano Polonelli
JournalAIDS (London, England) (AIDS) Vol. 20 Issue 7 Pg. 975-80 (Apr 24 2006) ISSN: 0269-9370 [Print] England
PMID16603848 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-HIV Agents
  • HIV Envelope Protein gp160
  • Peptides
  • RNA, Viral
  • Receptors, CCR5
  • Receptors, CXCR4
  • Zidovudine
Topics
  • AIDS-Related Opportunistic Infections (drug therapy, immunology, virology)
  • Anti-HIV Agents (immunology, therapeutic use)
  • CD4-Positive T-Lymphocytes (immunology)
  • Cells, Cultured
  • Down-Regulation (immunology)
  • HIV Envelope Protein gp160 (chemistry)
  • HIV Infections (drug therapy, immunology, virology)
  • HIV-1 (drug effects, physiology)
  • Humans
  • Leukocytes, Mononuclear (immunology)
  • Molecular Mimicry (immunology)
  • Peptides (chemistry, immunology, therapeutic use)
  • RNA, Viral (analysis)
  • Receptors, CCR5 (immunology)
  • Receptors, CXCR4 (immunology)
  • Sequence Alignment
  • Virus Replication (drug effects, immunology)
  • Zidovudine (immunology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: